Compare Incyte Corporation (INCY) vs Cloudflare Inc (NET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Cloudflare Inc — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.65B), while Cloudflare Inc trades at $306.18 (market cap $110.59B). The key difference: Cloudflare Inc is far larger — about 4.5× Incyte Corporation's market cap, and Cloudflare Inc is trading nearer its 52-week high, Incyte Corporation nearer its low. Which is the better fit depends on your goals.
| INCY | NET | |
|---|---|---|
Market Cap | $24.65B | $110.59B |
Sector | Health | Technology |
52-Week High | $129.93 | $310.40 |
52-Week Low | $81.61 | $160.16 |
Enterprise Value | $20.15B | $109.96B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Cloudflare Inc
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Read more on NET →
